Search
for
Sort by
Research 961–990 of 1000+
- 1262 ONE YEAR FINASTERIDE THERAPY IN MEN WITH A SERUM PSA GREATER THAN 4 NG/ML WHO HAD UNDERGONE REPEAT BIOPSY
- Dual effects of 5α-reductase inhibitor dutasteride on androgenetic alopecia and acne vulgaris
- Invalidation of a commercially available human 5α-dihydrotestosterone immunoassay
- Kombinationsbehandlung des BPS mit Tamsulosin und Finasterid
- Response to: “finasteride prescribed for hair loss consistently leads to depression”
- Finasteride-induced recurrent aphthous ulceration–like lesions: a case report with dechallenge–rechallenge confirmation
- CAFFEINE – A POPULAR STIMULANT AS A CAUSE OF INSOMNIA AMONG MEDICAL STUDENTS – A REVIEW OF THE LATEST LITERATURE
- Keyora Integrated Nutritional Modulation of the Redox–NO–Androgen Axis in Male Endocrine, Reproductive, and Metabolic Disorders
- The enzyme and inhibitors of 4-ene-3-oxosteroid 5α-oxidoreductase
- Acute liver damage due to <i>Serenoa repens</i>: a case report
- Effect of a novel steroid (PM-9) on the inhibition of 5α-reductase present in Penicillium crustosum broths
- Measuring the Burden of Disease in Korea Using Disability-Adjusted Life Years (2008–2020)
- Risks of Skin, Hair, and Nail Supplements
- Hypertension: sex-related differences in drug treatment, prevalence and blood pressure control in primary care
- Disproportional signal of sexual dysfunction reports associated with finasteride use in young men with androgenetic alopecia: A pharmacovigilance analysis of VigiBase
- A comment on psychological distress and women’s hair loss related to the COVID-19 pandemic
- 5-Alpha Reductase Inhibitor Use and Prostate Cancer Prevention: A Victim of the Times?
- Effects of platelet-rich plasma application on hair follicle count, telogen/anagen ratio, and miniaturized hair ratio in patients with androgenic alopecia: alone or in combination with other treatments
- Post-finasteride syndrome - a true clinical entity?
- Saw palmetto extract: A dermatologist's perspective
- Effects of the use of finasteride on prostate volume and serum PSA in young patients
- Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide
- Simultaneous Target-Mediated Drug Disposition-Pharmacodynamic (TMDD-PD) Modeling of Finasteride and Dutasteride: Impact of Target Binding and Turnover on Non-linear Pharmacokinetics
- Urinary Retention in Patients with BPH Treated with Finasteride or Placebo over 4 Years
- Combined Sabal and Urtica extract vs finasteride in BPH (Alken stage I–II)
- Reduced levels of 5-α reductase 2 in adult prostate tissue and implications for BPH therapy
- Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride?
- Effect of a Benign Prostatic Hyperplasia (BPH) Xenobiotic - Croton membranaceus Müll.Arg. Root Extract on CYP1A2, CYP3A4, CYP2D6, and GSTM1 Drug Metabolizing Enzymes in Rat Model
- PD19-08 MARIJUANA, ALCOHOL, ED AND DEPRESSION: EPIDEMIOLOGIC CORRELATIONS WITH BPH/LUTS
- Modulation of AR-FGF-2-TGF beta Axis by Cosmos caudatus Suppresses Prostatic Epithelial Proliferation in a BPH Rat Model: A Comparative Study with Finasteride